Mortality rate of patients with asymptomatic primary biliary cirrhosis diagnosed at age 55 years or older is similar to that of the general population

被引:19
作者
Kubota, Junichi [1 ]
Ikeda, Fusao [1 ]
Terada, Ryo [1 ]
Kobashi, Haruhiko [1 ]
Fujioka, Shin-ichi [2 ]
Okamoto, Ryoichi [3 ]
Baba, Shinsuke [4 ]
Morimoto, Youichi [5 ]
Ando, Masaharu [6 ]
Makino, Yasuhiro [7 ]
Taniguchi, Hideaki [8 ,9 ]
Yasunaka, Tetsuya [1 ]
Miyake, Yasuhiro [1 ]
Iwasaki, Yoshiaki [1 ]
Yamamoto, Kazuhide [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008558, Japan
[2] Okayama Saiseikai Gen Hosp, Dept Internal Med, Okayama, Japan
[3] Hiroshima City Hosp, Dept Internal Med, Hiroshima, Japan
[4] Kagawa Prefectural Cent Hosp, Dept Internal Med, Takamatsu, Kagawa, Japan
[5] Fukuyama City Hosp, Dept Internal Med, Fukuyama, Hiroshima, Japan
[6] Mitoyo Gen Hosp, Dept Internal Med, Kanonji, Japan
[7] Natl Hosp Org Iwakuni Clin Ctr, Dept Gastroenterol, Iwakuni, Japan
[8] Sumitomo Besshi Hosp, Dept Internal Med, Niihama, Japan
[9] Tsuyama Cent Hosp, Dept Gastroenterol, Okayama, Japan
关键词
Primary biliary cirrhosis; Age difference; Mortality rate; URSODEOXYCHOLIC-ACID THERAPY; RANDOMIZED CONTROLLED-TRIALS; LIVER FIBROSIS PROGRESSION; NATURAL-HISTORY; AUTOIMMUNE HEPATITIS; SURVIVAL; COHORT;
D O I
10.1007/s00535-009-0090-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Recent routine testing for liver function and anti-mitochondrial antibodies has increased the number of newly diagnosed patients with primary biliary cirrhosis (PBC). This study investigated the prognosis of asymptomatic PBC patients, focusing on age difference, to clarify its effect on the prognosis of PBC patients. The study was a systematic cohort analysis of 308 consecutive patients diagnosed with asymptomatic PBC. We compared prognosis between the elderly (55 years or older at the time of diagnosis) and the young patients (< 55 years). The mortality rate of the patients was also compared with that of an age- and gender-matched general population. The elderly patients showed a higher aspartate aminotransferase-to-platelet ratio, and lower alanine aminotransferase level than the young patients (P < 0.01 and P = 0.03, respectively). The two groups showed similar values for alkaline phosphatase and immunoglobulin M. Death in the young patients was more likely to be due to liver failure (71%), while the elderly were likely to die from other causes before the occurrence of liver failure (88%; P < 0.01), especially from malignancies (35%). The mortality rate of the elderly patients was not different from that of the age- and gender-matched general population (standardized mortality ratio, 1.1; 95% confidence interval, 0.6-1.7), although this rate was significantly higher than that of the young patients (P = 0.044). PBC often presents as more advanced disease in elderly patients than in the young. However, the mortality rate of the elderly patients is not different from that of an age- and gender-matched general population.
引用
收藏
页码:1000 / 1006
页数:7
相关论文
共 33 条
[1]
PRIMARY BILIARY CIRRHOSIS [J].
AHRENS, EH ;
PAYNE, MA ;
KUNKEL, HG ;
EISENMENGER, WJ ;
BLONDHEIM, SH .
MEDICINE, 1950, 29 (04) :299-364
[2]
Autoimmune hepatitis (AIH) in the elderly: A systematic retrospective analysis of a large group of consecutive patients with definite AM followed at a tertiary referral centre [J].
Al-Chalabi, Thawab ;
Boccato, Sylvia ;
Portmann, Bernard C. ;
McFarlane, Ian G. ;
Heneghan, Michael A. .
JOURNAL OF HEPATOLOGY, 2006, 45 (04) :575-583
[3]
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis [J].
Angulo, P ;
Batts, KP ;
Therneau, TM ;
Jorgensen, RA ;
Dickson, ER ;
Lindor, KD .
HEPATOLOGY, 1999, 29 (03) :644-647
[4]
DIMINISHED SURVIVAL IN ASYMPTOMATIC PRIMARY BILIARY-CIRRHOSIS - A PROSPECTIVE-STUDY [J].
BALASUBRAMANIAM, K ;
GRAMBSCH, PM ;
WIESNER, RH ;
LINDOR, KD ;
DICKSON, ER .
GASTROENTEROLOGY, 1990, 98 (06) :1567-1571
[5]
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis [J].
Corpechot, C ;
Carrat, F ;
Bonnand, AM ;
Poupon, RE ;
Poupon, R .
HEPATOLOGY, 2000, 32 (06) :1196-1199
[6]
Dicker A P, 1989, Cancer Commun, V1, P7
[7]
Ursodeoxycholic acid for patients with primary biliary cirrhosis: An updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses [J].
Gong, Yan ;
Huang, Zhibi ;
Christensen, Erik ;
Gluud, Christian .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (08) :1799-1807
[8]
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis [J].
Goulis, J ;
Leandro, G ;
Burroughs, AK .
LANCET, 1999, 354 (9184) :1053-1060
[9]
Management of primary biliary cirrhosis [J].
Heathcote, EJ .
HEPATOLOGY, 2000, 31 (04) :1005-1013
[10]
Cancer risk in primary biliary cirrhosis: a study in northern England [J].
Howel, D ;
Metcalf, JV ;
Gray, J ;
Newmann, WL ;
Jones, DEJ ;
James, OFW .
GUT, 1999, 45 (05) :756-760